The structural antigen Band II was present in ceils infected with either type I or type 2 herpes simplex virus. Antiserum to Band II neutralized the infectivity of both virus types. General antisera to either type exhibited type specific neutralizing activity after absorption with heterologous antigen. Absorption of the antisera with Band I[ antigen from cells infected with either type I or type 2 virus also abolished the type common but not the type specific neutralizing activity. Fractions obtained by preparative polyacrylamide gel electrophoresis have been examined in serum blocking tests. The results suggest that particles of herpes simplex virus possess at least two type specific antigens and one type common antigen (Band II); interaction of any of these with the corresponding antibody causes loss of virus infectivity.
INTRODUCTION
Type I strains of herpes simplex virus, which are usually oral isolates, can be differentiated in neutralization tests from type 2 strains, which are usually genital isolates, because anfisera against one type usually neutralize the homologous strains better than the heterologous strains (Plummer, 1964; Pauls & Dowdle, I967; Rawls et al. I968) . However, cells infected with herpes simplex virus appear to contain antigens specific for the type of the infecting virus as well as antigens common to the two types (Geder & Skinner, I97I; Nahmias et al. 1971 ; Schneweis & Nahmias, 1971) . Further, both Geder & Skinner 0971) and Nahmias et al. (I97I) have shown that only the homologous type is neutralized by antisera which have been absorbed with cells infected with the heterologous type. This would suggest that both cross-reacting (or type common) and type specific antigens may be involved in neutralization of these viruses. In this paper we have confirmed that type specific sera can be made by absorption of antisera with extracts of cells infected with the heterologous type. We have been able to relate this finding to the earlier observation that antiserum to a structural antigen 'Band II' (Watson, 1969) neutralizes the infectivity of type I virus (Watson & Wildy, 1969) . We now show that this antiserum neutralizes both types i and z and present evidence that anti-Band II antibodies in general, or polyprecipitin, antisera account for the cross-neutralization of the two types. Our work suggests that there are at least two type specific structural antigens in particles of the two types and interaction of either of these with their antibodies also leads to neutralization. tal points (apart from the origin) lying on a straight line plot. The least-squares method was used to fit the best straight line through the origin to the experimental points.
Electrophoretie procedures. Infected cell extracts were homogenized with fluorocarbon, centrifuged at iooooog for I h and concentrated by vacuum dialysis and then 'electrofiltered' by electrophoresing through 3"5 ~ (w/v) acrylamide gels as previously described (Watson, ~969) . The resultant 'electrofiltrates' contained no detectable infective virus but all the diffusible antigens of the original cell extract. These antigens were separated by preparative electrophoresis through 7 ~ (w[v) acrylamide gels, the antigens being extracted from the gel at the end of the run by elution from sliced gel segments (Watson, I969) . The peak fraction of Band II antigen activity was identified either by agar gel immunodiffusion or complement fixation (see below) against monoprecipitin antiserum to Band II antige~J.
Tests for serum blocking activity. Electrofiltrates or fractions from preparative electrophoresis were tested for their ability to block the virus neutralizing activity of general antisera, of general antisera absorbed with heterologous antigen or of monoprecipitin antisera to Band II antigen. The blocking reaction was performed by overnight incubation at 4 °C of z5 #1 vol. of appropriately diluted antigen (i.e. electrofiltrate or fraction from preparative electrophoresis) with 25 #1 of appropriate dilution of antiserum. The mixture (which we shall term the blocking mixture) was then warmed to 25 °C and 50 #1 virus containing about 4 x Io 4 p.f.u./ml was added. Surviving virus was determined by assay of a I[Ioo dilution of this mixture after incubating it for I h at 25 °C. In some experiments, duplicate blocking mixtures were prepared independently and tested for neutralizing activity to check the reproducibility of the results. Control blocking mixtures were also prepared and assayed for neutralizing activity. When electrofiltrates were being tested, the control mixture consisted of phosphate buffered saline (Dulbecco & Vogt, I954) and the appropriate dilution of antiserum. In tests on serum blocking activity of fractions from preparative electrophoresis, the control mixture was made by adding the appropriately diluted antiserum to 'last fraction', i.e. the eluate from an acrylamide slice beyond the phenol red marker. Tests with fractions from electrophoresis of uninfected cell extracts indicated that none of the buffers, gel components, etc., had any effect either on the infectivity of the test virus or on its neutralization by antiserum.
Complement fixation. Band II activity in fractions from preparative electrophoresis was tested by complement fixation with antiserum to Band II. The optimal dilution of antiserum was selected by a preliminary titration with the peak fraction identified by immunodiffusion tests. The tests were carried out in microtitre plates (TakS_tsy). Antiserum and 3 units of complement were added to doubling dilutions of each fraction before overnight incubation at 4 °C. The plates were then incubated at 37 °C for I h before addition of sensitized sheep erythrocytes and incubation for a further 3 o rain at 37 °C. The unlysed cells were then allowed to settle at 4 °C and the end-points read as the antigen dilution corresponding to I unit of complement unfixed. Controls showed that there were no pro-or anti-complementary effects with either the fractions from electrophoresis or with the antiserum at the dilution used.
RESULTS
The neutralization of type I and type 2 herpes simplex by antiserum to Band H Antiserum to Band II neutralized both type I and type 2 strains of herpes simplex virus (Fig. I) . From these results k 1 (the rate constant for neutralization of type I virus) was o.I8 and k2 (the corresponding value for neutralization of type 2 virus) was o.o6. In immuno- diffusion tests with extracts of cells infected with either type I or type 2 virus, the antiserum gave single precipitin bands showing reactions of identity.
The neutralization properties of antisera absorbed with heterologous antigen

General antiserum to type I virus absorbed with type 2 antigen
A general antiserum to type I virus was absorbed with an extract of cells infected with type 2 virus as described in Methods. The neutralization properties of the resulting absorbed antiserum were compared with the unabsorbed antiserum in a number of neutralization tests against both type I and type 2 virus (Fig. 2) . The values of -log V[Vo for type 2 virus treated with the unabsorbed serum were about half the corresponding values for type I virus over the range of dilutions tested. The absorption of the antiserum with type 2 antigen has plainly impaired its neutralizing activity against type I virus but has completely removed any activity against type 2 virus. Thus, at the lowest dilution tested, the absorbed serum has reduced the titre of type I virus by over 2 log units, whereas the titre of type 2 virus does not differ significantly from that of the pre-immune control. Table I lists the k values for the neutralization of types I and z virus by the absorbed and unabsorbed antisera. Plainly, the insignificant neutralization of type a virus by the absorbed serum does not allow determination of a k value by the methods previously outlined. However, we have recorded in Table I an upper limit calculated from the 95 ~ confidence limit of -log V/Vo for the lowest dilution of absorbed serum used. Whereas kl/k2 (the ratio of the k values against type i and type 2 viruses, respectively) was I'9, after absorption it was significantly greater than 87 and the absorbed serum was almost completely type specific in its neutralizing activity. Although Fig. 2 and Table I show that the neutralizing activity of the antiserum for type I virus was greatly reduced by absorption with type z antigen, this residual activity was still significant. Similar results have been obtained in six experiments using two different antisera. These experiments suggested that the residual neutralizing activity after absorption was entirely type specific. However, it is possible that this activity was due to antibodies less Ratio of k's of unabsorbed antisera 4"9 >> 227 absorbed * k did not differ significantly from zero and value quoted represents upper 95 ~ confidence limit.
readily absorbed by the type 2 antigen. We have therefore tested the neutralizing activity of the antiserum after absorption with three different concentrations of type 2 antigen. Three mixtures of antiserum and infected cell extract were prepared which contained, respectively, 5 x i0 a, I x I09 and 1"5 x io 9 infected cells per ml of antiserum. The antiserum in each mixture was concentrated to its original vol. and its neutralizing activity tested against type I virus. The results are shown in Table 2 . The neutralizing activity of the antiserum was not apparently reduced by absorption with increased amounts of type 2 antigen. Further, in a separate experiment we have shown that the neutralizing activity of the antiserum for type I virus could not be abolished by absorbing I ml antiserum with the extract from 2 x Io TM cells infected with type 2 virus. By contrast, we have routinely found that the neutralizing activity could be abolished by absorption of I ml antiserum with extract from Io 9 cells infected with type I virus. We conclude that the residual neutralizing activity of the antiserum in these experiments was entirely specific for the type I virus. So far, we have only shown that this residual neutralizing activity of the absorbed antisera was specific for the strain of type I virus we have used. Accordingly, we tested the effect of an absorbed antiserum on three type I strains and on three type 2 strains. Table 3 shows that the absorbed antiserum significantly depressed the infectivity of all three type I strains but had a negligible effect on the three type 2 strains. It therefore seems reasonable to assert that the residual neutralizing activity of the absorbed antiserum was entirely type specific.
General antiserum to type 2 virus absorbed with type I antigen
Reciprocal experiments to those in the preceding section have been performed with type 2 antiserum after absorption with type I antigen. The results are shown in Fig. 3 . The neutralizing activity against the homologous virus was once again impaired but not abolished, whereas the absorbed serum caused no detectable neutralization of the heterologous virus. Thus, at the lowest dilution of antiserum tested, the absorbed serum had no effect on type I virus (even when the time of incubation in the neutralization test was increased to 3 h) but decreased the infectivity of type 2 virus by almost 2 logs. Table 4 lists the k values for the unabsorbed antiserum against types I and 2 viruses and of the absorbed serum against type 2 virus. Once again, we have quoted an upper limit for the k value of the absorbed serum against type 2 virus. The k~/kt ratio (ratio of k values against type 2 and type I virus, respectively) was 2. 9 for the unabsorbed antiserum and significantly greater than I8O for the absorbed antiserum. Once again, we have shown that the type specific neutralizing activity of the absorbed antiserum was unchanged after absorption with increasing amounts of absorbing antigen. Finally, experiments with three type I and three type 2 strains showed that the neutralizing activity of absorbed antiserum was truly type specific. 
The role of Band H in neutralization of type I and type 2 herpes simplex virus
The experiments in the preceding sections indicated that antisera to type I and type 2 viruses contained both type specific and type common neutralizing antibodies. Since we have shown that antiserum to Band II neutralizes both types, it seemed likely that some or all of the cross neutralizing activity was due to antibodies to Band II in the general antisera. The experiments in this section were designed to test this hypothesis.
Serum blocking activity against type I antiserum of Band H antigen prepared from cells infected with type I virus
Band II antigen was prepared from cells infected with herpes simplex virus type I and several dilutions of the antigen were tested for serum blocking activity against a general antiserum to type I virus. The results are shown in Fig. 4 . Duplicate mixtures were prepared for each concentration of antigen except the highest and the residual neutralizing activity of each determined separately. The results for each mixture are shown in Fig. 4 . The neutralizing activity (i.e. -log V[ Vo) of the antiserum was reduced at the three highest concentrations of Band II antigen used. However, the highest concentration of Band II (overall dilution of I/z of Band II in the blocking mixture with antiserum) did not completely abolish the neutralizing activity of the antiserum. This effect was apparently not due to insufficient antigen since the mixtures containing the two highest concentrations of Band II had the same neutralizing activity. In other words, at this ' saturation' level doubling the concentration of Band II in the blocking mixture did not effect any further reduction of the neutralizing activity of the antiserum. Thus, some of the neutralizing activity of the general antiserum to type r virus could not be removed by previous absorption with Band II antigen. This result was obtained reproducibly using several different preparations of Band II antigen. We next compared the serum blocking activity of a preparation of Band II antigen with that of the electrofiltrate of infected cell extract from which it was derived. Immunodiffusion tests with antiserum to Band lI antigen showed that the concentration of Band II in the electrofiltrate was about ten times that in the Band I[ preparation. In presenting the results of the serum blocking tests (Fig. 5 ) the scales have been adjusted to produce coincidence of dilutions of electrofiltrate and of Band I1 fraction with equal content of Band II antigen. Dilutions of electrofiltrate always showed greater blocking activity than expected from their content of Band II antigen. Inaccuracies in the assay of the antigen cannot explain why electrofiltrate used at an overall dilution of I/8O showed significantly more blocking activity than Band II antigen used at a dilution of I/2 although its content of Band II antigen was fourfold lower. The results suggested, therefore, that electrofiltrate contained an antigen with serum blocking activity which was not present in the Band II antigen preparation. This conclusion was reinforced by the fact that addition of increasing amounts of electro-filtrate caused a progressive reduction in the neutralizing activity of the antiserum and finally completely abolished it. By contrast, a saturation effect was once again observed with Band II antigen; addition of increasing quantities of Band II antigen did not cause further loss of neutralizing activity.
Antisera to type ~ virus thus retained neutralizing activity for the homologous virus after absorption with excess Band II antigen. We have tested such an absorbed antiserum for neutralizing activity against type 2 herpes simplex virus. The antiserum was shown to be blocked to the saturation level by experiments similar to those of Figs. 4 and 5-The antiserum was mixed with an equal vol. of either type ~ virus or type 2 virus and the residual infectivity assayed after incubating the mixtures for I h and 3 h. Each mixture was prepared in duplicate and the neutralizing activity of each mixture determined separately. The results are shown in Fig. 6 . There was no significant neutralization of type 2 virus; the infectivity was insignificantly decreased even after incubation for 3 h, while the infectivity of type I virus was decreased after I h and was even lower after 3 h. After 3 h, -log V/Vo for type I was o'487 (the results from the duplicate mixtures were combined in this calculation). . The survival of type 2 virus was significantly greater than this after incubation with the absorbed serum. The mean plaque count per dish of type 2 virus incubated with pre-immune serum for 3 h was 5I, so the expected plaque count for -log V/Vo of o. I48 would thus be 36. The absorbed mean plaque count per dish for type 2 virus incubated with the absorbed antiserum was 52 + 3 (95 % confidence limit of the mean plaque count for 8 Petri dishes) -clearly significantly higher than the value expected for unaltered type specificity. Thus, the type specificity of the antiserum to type I virus has been significantly increased by absorption with Band II antigen and indeed the absorbed antiserum did not have any significant effect on the infectivity of type 2 virus. Absorption of a general antiserum to type I virus with Band II antigen presumably rendered antibodies to Band II ineffective in neutralization. Accordingly, we can conclude that these antibodies were responsible for the cross neutralizing activity of the general antiserum, but that the antiserum contained antibodies to at least one other antigen not present in Band II fraction and these antibodies had type specific neutralizing activity.
Serum blocking activity against type 2 antiserum of Band II antigen prepared from cells in. feeted with type I virus
We have shown that cells infected with type 2 virus contain Band II antigen and that antiserum to Band II antigen (prepared from ceils infected with type ~ virus) neutralizes the infectivity of type 2 virus. General antisera to type 2 virus neutralize both types I and 2 viruses and it would seem reasonable to account for this cross neutralizing activity by the presence of antibodies to Band II antigen in the general antiserum.
In accord with this we found that absorption with Band II antigen (prepared from cells infected with type I virus) completely abolished the neutralization of type ~ virus by antiserum to type 2 virus. A saturation effect was, however, observed in the neutralization of type 2 virus by the absorbed sera; the specific neutralizing activity of antiserum to type 2 virus could not be abolished by absorption with Band II antigen. 
Serum blocking activity aga&st type I ant&erum of Band H antigen prepared from cells infected with type 2 virus
Since we have shown that ceils infected with type 2 virus contain Band lI antigen, it was therefore possible to prepare a Band II fraction by preparative electrophoresis of an extract of these cells. Once again, the peak fraction of Band II activity was determined by immunodiffusion tests against antiserum to Band II antigen prepared from cells infected with type I virus. This fraction was then tested for serum blocking activity against a general antiserum to type i virus. The serum blocking activity was compared with that of a Band II fraction prepared from cells infected with type I virus. Band II antigen from either type I or type z infected cells should both remove the cross-neutralizing activity of the antiserum to type I virus. Further, neither Band II antigen should affect the type-specific neutralizing activity and we should therefore expect that the 'saturation' level should be the same for both Band II antigen preparations -that is, general antiserum to type I virus should have the same neutralizing activity for type I virus after absorption with excess type I Band II as after absorption with excess type 2 Band II antigen. The results are presented in Fig. 7 Once again, results for duplicate mixtures are shown separately. A saturation effect was observed with type 2 Band II. Addition of increased amount of this preparation did not further reduce the neutralizing activity of the type ~ antiserum for type I virus. Further, this residual neutralizing activity was entirely type specific; the antiserumantigen mixtures containing the two highest concentrations of type 2 Band II had no significant effect on type 2 virus (the neutralization tests with type 2 virus were incubated for 3 h to increase the sensitivity of detection of activity). However, the antiserum absorbed with excess type 2 Band II fractions had a greater neutralizing activity against type I virus than the antiserum absorbed with excess type ~ Band I[ fraction. The difference was significant and reproducible. Thus, the Band II fractions prepared from cells infected with type and type 2 viruses were equally effective in blocking cross-neutralizing activity of the type I antiserum. However, the type I Band II antigen caused a greater reduction in the neutraliz-
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ing activity of the antiserum for type I virus than the type 2 Band II antigen. Thus, the type I Band II fraction could apparently interact with type specific antibodies in the general antiserum to type I virus which were unaffected by the type 2 Band II fraction. We have repeatedly shown that type I Band I[ fractions were incapable of completely blocking the type specific neutralizing activity of general antiserum to type I virus. We accordingly conclude that there must be at least two kinds of type specific neutralizing antibody in the general antiserum to type I virus. One of these must correspond to an antigen present in the type I Band II fraction. The other kind of type specific neutralizing antibody must correspond to an antigen which is not present in the type I Band II fraction. We shall return to this point in a later section.
Tests on serum blocking activity of fractions from preparative electrophoresis of extracts of type I infected cells
The experiments in the preceding sections have indicated that general antisera to type I virus contain type-specific neutralizing antibodies related to an antigen not present in the Band II fraction. Accordingly, a number of fractions from preparative electrophoresis were tested for serum blocking activity against a general antiserum to type I virus. The greatest activity (i.e. greatest virus survival) was found in fraction 8 (Fig. 8 a) . The peak of Band II activity measured by complement fixation was in fraction 9 which showed only marginally less blocking activity than fraction 8. Fractions 6 to I2 all showed significant blocking and the broad peak was in marked contrast to the fairly sharp peak of Band II activity shown by complement fixation (Fig. 8 b) . By contrast, the blocking activity of the fractions for an antiserum to Band II antigen (Fig. 8 b) corresponded fairly well to the complement fixing activity against the antiserum. The virus survivals for fractions 7, 8, 9, Io, ~ I did not differ significantly from Ioo ~, i.e. neutralizing activity of the serum was completely blocked by these fractions. The serum blocking activity of fraction 6 for antiserum to Band II was significantly less than that of fraction 9. By contrast, fractions 6 and 9 did not differ in their blocking activities against the general antiserum. This suggests that fraction 6 may have contained an antigen other than Band II which blocked the neutralizing activity of the corresponding antibodies. This is supported by the fact that the complement fixation results showed that fraction 6 contained I6 times less Band II antigen than fractions 9 and I]~6 dilutions of Band II peak fractions have never shown any serum blocking activity against general antisera (cf . Figs. 4 , 5)-Further confirmation has come from experiments which showed that a mixture of fractions 6 and 9 showed greater serum blocking activity than the individual fractions. We would therefore expect fraction 6 to show serum blocking activity against an antiserum containing only type specific antibodies. Such an antiserum was prepared by absorption of the general antiserum with excess type 2 antigen as described previously. The absorbed serum was made from the batch of general antiserum used in the above assays of serum blocking activity. It was used at the same dilution as the unabsorbed general antiserum in tests for serum blocking activity of the same electrophoresis fractions. The results are shown in Fig. 8 (c) . Fraction 6 showed the greatest blocking activity (if we exclude fraction I which we believe contained aggregated antigens-see Watson, I969) and in contrast to the results with the general antiserum it showed significantly more blocking activity than fraction 9-However, fraction 9 (i.e. the Band II peak fraction) also showed significant blocking activity against the absorbed antiserum and this result was observed reproducibly with several batches of absorbed antiserum using Band I[ fractions from several electrophoresis experiments. This result therefore reinforces our earlier conclusion that the Band II peak fraction contains a type specific antigen capable of reacting with type specific neutralizing antibodies. At this stage we cannot say whether this antigen is present as a separate entity in the Band lI fraction or whether it represents a type specific antigenic determinant on Band II antigen itself. In the latter case, we would then expect that antiserum to Band II would contain both type-specific and cross-reacting neutralizing antibodies. The experiments in the following section were designed to investigate this point.
The neutralizing activity of antiserum to Band H antigen after absorption with type 2 antigen
We have concluded that antibodies to Band II account for the cross-neutralizing activity of general antisera. So far, however, we have not shown that all the neutralizing activity of antiserum to Band II is cross-reacting. If it were, then absorption of the antiserum with excess type 2 antigen should completely abolish its neutralizing activity for both types I and 2 viruses. Four antisera to Band II antigen (prepared from cells infected with type I virus) were absorbed with type z antigen. Extract from 5 x Io s infected ceils was used to absorb I ml of antiserum. As shown in Table 5 , all the antisera had significant residual neutralizing activity for type I virus. They had no residual neutralizing activity for type 2 virus. We have not determined k values for the antisera in this experiment but Table 5 shows that the neutralizing activity of antisera 280 and 413 after absorption was roughly equivalent to that of unabsorbed antisera used Io times more dilute. The activity of 226 after absorption was slightly greater than that of unabsorbed 226 used io times more dilute. The activity of 432 after absorption was slightly less than the unabsorbed serum used 2o times more dilute.
Finally, we may note that the residual neutralizing activity of these antisera could not be reduced by absorbing with greater amounts of the extract of cells infected with type z virus. We accordingly conclude that the antiserum to Band Ii has some type specific neutralizing activity. We earlier concluded that Band II fraction from preparative electrophoresis contained an antigen capable of reacting with type specific neutralizing antibody in general antiserum. This antibody presumably corresponds to the type specific activity of the antiserum to Band II.
We may note here that the absorbed antiserum gave no precipitin line in immunodiffusion tests with type I antigen. Further, we have been unable to detect any evidence of spur formation when antiserum to Band II and general antiserum to type 2 virus were placed in adjoining wells in tests against Band II antigen (Fig. 9) . The precipitin line given with the antiserum to Band II-showed complete identity to that given with the type z antiserum.
DISCUSSION
We have clearly shown that general antisera to type I and 2 herpes simplex virus contain type specific and cross-reacting or type common neutralizing antibodies. Since we have only used two different type I antisera and one type 2 antiserum, we cannot say that all antisera will contain both types of antibody. However, the fact that type specific antibodies can be demonstrated in any antiserum indicates that the infective virus particle must possess type specific and cross-reacting antigens. Interaction of either with its appropriate antibody causes neutralization of infectivity.
We have shown that there must be at least two type specific antigens. Since the antigens in the Band II fraction abolished the cross-neutralizing activity of general antisera, we conclude that if there is more than one cross-reacting antigen participating in neutralization it must be present in the Band II fraction. Deficiencies in the antisera could also lead to an underestimate of the number of antigens involved. Plainly, we can only relate an antigen to neutralization if the antisera used contain antibody to it.
Immunodiffusion tests showed Band II antigen was present in ceils infected with either type Iort ype 2 infected cells. Since antiserum to Band II antigen neutralized both virus types, it seems reasonable to conclude that this antigen is present in the particles of both types of herpes simplex virus. However, we have also shown that antiserum to Band II contained type specific neutralizing antibodies. This might mean that Band II antigen has both type common and type specific antigenic determinants and that antibodies to either could neutralize the infectivity of type T virus. The hexon antigen of adenoviruses possesses both type specific and cross-reactive determinants although only antibodies to the type specific component neutralize infectivity (Wilcox & Ginsberg, 1963) . However, in immunodiffusion tests antiserum to hexon antigen gave reactions of partial identity between homologous and heterologous antigens (Pereira & Laver, 197o), while Petterson (197I) has shown that the antiserum still reacted with homologous hexon in immunodiffusion tests after absorption with heterologous hexon antigen. We have been unable to detect such a type specific determinant in similar tests with antiserum to Band II. Accordingly, we must allow the possibility that the type specific neutralizing activity is due to antibody against a contaminating antigen present in the Band II precipitin lines used for preparation of the antisera. Plainly, the results for the four antisera we have used indicate that any contamination was a reproducible occurrence. If we allow that the type specific neutralizing antibody is due to contamination, we must obviously consider whether we are justified in correlating the type common neutralizing activity of antisera to Band II with their ability to produce a type common precipitin line in immunodiffusion tests. This difficulty can never be completely resolved; the two activities can at best be correlated but they can never be equated. However, we can say that titres of antisera to Band II in immunodiffusion tests seem to parallel their k values in neutralization tests.
Our results show that at least two of the type specific antigens found in infected cells (Geder & Skinner, I97I ; Nahmias et al. I97I ; Schneweis & Nahmias, 1971) are present in the virus particle. This conclusion is in accord with the results of Halliburton 0972), who showed that some of the virus specific proteins in cells infected with type I virus were separable by polyacrylamide gel electrophoresis in SDS from the corresponding proteins from cells infected with type 2 virus, and that at least some of the proteins which differed in this way were structural.
At this stage we know nothing of the mechanisms by which the different types of antibody neutralize virus infectivity. It has been suggested that both naked and enveloped herpes simplex particles are infective (Watson, Wildy & Russell, I964; Stein, Todd & Mahoney, I97o) . Spring & Roizman 0968) showed that intranuclear particles were infective and Roizman 0969) concluded that these particles lacked an outer envelope. It might therefore be expected that if there are two kinds of infective particle these would be neutralized by antibodies to different antigens. However, in our experiments there was no significant proportion of virus unneutralized by either antiserum to Band II or by the type specific neutralizing antisera produced by absorption. Accordingly, we can conclude either that the preparations of intracellular virus we used in the neutralization tests contained only one kind of infective particle or that the antisera were able to neutralize both kinds of particle. We shall return to this point in a later publication. In the meantime, we may say that there is a precedent for virus infectivity being neutralized by antibodies acting at different antigenic sites. Rowlands, Sangar & Brown 0970 showed that infectivity of foot-and-mouth disease virus was lost after interaction of antibodies at either of two different sites on the virus particle. Their work suggested that the two kinds of antibody interfered with different stages of the infective cycle. This is not a necessary condition in every case where multiple antigenic sites can be involved in neutralization, Thus, interaction of one antigenic site could have a steric effect on a second site playing a critical role in the infective cycle. Thus, although all the different kinds of antibodies react primarily at different sites, they could all destroy infectivity by a secondary effect on the same site. Such reactions would be analagous to those termed 'steric neutralization' by Webster & Laver 0970, who described neutralization of the neuraminidase of influenza virus particles by antisera specific for the haemagglutinin and vice versa.
The cross-neutralization of type I and type z herpes simplex virus has hampered the interpretation of sero-epidemiological data for type 2 infections (Rawls et al. I968; Nahmias et al. I97o; Skinner, Thouless & Jordan, I97 0. The demonstration of antibodies specific for type 2 virus would, of course, be strong evidence for a previous infection with type a virus. Plainly, application of our results should make it possible to detect type specific antibodies in sero-epidemiological surveys. Thus, absorption of sera with the heterologous antigen or with Band II antigen should produce a type specific serum. A more convenient method, of course, would be the preparation of type specific antigens which could then be used in complement fixation tests for detection of type specific antibody in sera. Theoretically, at any rate, there is no reason why such antigens could not be prepared. However, it should be noted that we have used only a limited number of antisera which were raised in experimental animals. Other experimental antisera or human sera obtained in epidemiological surveys may well contain only small amounts of type specific antibodies, in which case the tests we propose would be ineffective.
